Early experience with ocrelizumab in denmark. A population-based registry study

Authors :: Magyari, M.
Pontieri, L
Blinkenberg, M.
Papp, V.
Rasmussen, P.
Schäfer, Jakob
Berg, J.
Kant, M.
Mathiesen, H.
Jensen, M.
Sirakov, G.
Petersen, A.
Bramow, S.
Sellebjerg, F.
Source :: Magyari, M, Pontieri, L, Blinkenberg, M, Papp, V, Rasmussen, P, Schafer, J, Berg, J, Kant, M, Mathiesen, H, Jensen, M, Sirakov, G, Petersen, A, Bramow, S & Sellebjerg, F 2020, ' Early experience with ocrelizumab in denmark. A population-based registry study ', Multiple Sclerosis Journal, vol. 26, no. Suppl. 3, P0868, pp. 530-531 . < https://doi.org/10.1177/1352458520974937 >, Magyari, M, Pontieri, L, Blinkenberg, M, Papp, V, Rasmussen, P, Schäfer, J, Berg, J, Kant, M, Mathiesen, H, Jensen, M, Sirakov, G, Petersen, A, Bramow, S & Sellebjerg, F 2020, ' Early experience with ocrelizumab in denmark. A population-based registry study ', Multiple Sclerosis, vol. 26, no. Suppl. 3, P0868, pp. 530-531 . < https://journals-sagepub-com.auh.aub.aau.dk/toc/msja/26/3_suppl >
Publication Year :: 2020

Language :: English
Database :: OpenAIRE
Journal :: Magyari, M, Pontieri, L, Blinkenberg, M, Papp, V, Rasmussen, P, Schafer, J, Berg, J, Kant, M, Mathiesen, H, Jensen, M, Sirakov, G, Petersen, A, Bramow, S & Sellebjerg, F 2020, ' Early experience with ocrelizumab in denmark. A population-based registry study ', Multiple Sclerosis Journal, vol. 26, no. Suppl. 3, P0868, pp. 530-531 . < https://doi.org/10.1177/1352458520974937 >, Magyari, M, Pontieri, L, Blinkenberg, M, Papp, V, Rasmussen, P, Schäfer, J, Berg, J, Kant, M, Mathiesen, H, Jensen, M, Sirakov, G, Petersen, A, Bramow, S & Sellebjerg, F 2020, ' Early experience with ocrelizumab in denmark. A population-based registry study ', Multiple Sclerosis, vol. 26, no. Suppl. 3, P0868, pp. 530-531 . < https://journals-sagepub-com.auh.aub.aau.dk/toc/msja/26/3_suppl >
Accession number :: edsair.dedup.wf.001..3f35a23f0ba24b40dec3827cb5990f5a
Full Text :: https://doi.org/10.1177/1352458520974937